RegWardenFDA facility compliance records
Recall

Class I — Magellan Diagnostics, Inc.

Recalling firmMAGELLAN Diagnostics INC.
Registered facilityMagellan Diagnostics, Inc. (the firm's only registered facility)
ClassificationClass I
StatusTerminated
ReasonLeadCare Plus and LeadCare Ultra Blood Lead Testing Systems may generate falsely low lead concentrations in some blood samples. The issue is observed when blood samples are collected in tubes with lavender and tan rubber stoppers of the Becton Dickinson EDTA Vacutainer tubes, a collection device used with the testing system.
ProductMagellan Diagnostics LeadCare Ultra Blood Lead Test Kits Part Number: 80-0010
Quantity1016
DistributionNationwide Distribution
Initiated2014-11-29
Classified2017-05-17
Terminated2022-02-26
Recall numberZ-1926-2017
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class I recall — Magellan Diagnostics, Inc. (Z-1926-2017).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/76991/

Not open yet

Alerts for MAGELLAN Diagnostics INC.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.